In this episode of CEO Roadshow, we’re joined by Dr. Mitchell Steiner, CEO of Veru, an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer
Their stock trades on the NASDAQ under the ticker VERU.
About Veru Inc.
Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer.
To learn more, please visit www.verupharma.com/investors.
CEORoadshow.com is committed to providing our readers with useful information on publicly traded companies. CEORoadshow.com sometimes contracts with third parties or publicly traded companies and receives compensation from them for publishing information and opinions about the company and the trading market for their securities. CEORoadshow.com content should not be considered to be independent publications concerning the company.
Neither CEOROADSHOW.COM or any of its principals currently own or plan to own within 72 hours of publication any shares of the stocks mentioned in this video. For a full disclaimer please visit, CEOROADSHOW.COM/disclaimer.
CEOROADSHOW content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to the accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in CEOROADSHOW content and productions, or other investor relations materials and presentations are subject to change. Neither CEOROADSHOW nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. All data and information are provided for informational or entertainment purposes only. CEOROADSHOW is not a registered broker-dealer or a registered investment advisor.